IMAGENE.ME secures a 6 million PLN investment from ABAN.VC and NCBR Investment Fund to accelerate its expansion into international markets and solidify its leadership in personal genomics.

Target Company Overview

IMAGENE.ME is a Polish biotechnology firm that has been setting new standards in genomic research, advanced genetic diagnostics, and personalized health prevention. With a focus on expanding into international markets, the company has recently secured a significant investment of 6 million PLN, backed by the strategic support of ABAN.VC and NCBR Investment Fund (NIF). This funding will enable IMAGENE.ME to strengthen its presence in Poland and lay the groundwork to become a leader in Europe in the field of personal genomics, particularly in health prevention and longevity.

The company offers a unique integrated ecosystem for personal genomics, which includes advanced DNA analysis, expert-level result interpretation, and preventive and diagnostic support accessible through the IMAGENE.ME LIFE application and platform. This robust platform continually updates users on their genomic research results while providing personalized health advice, teleconsultations with physicians, and recommendations for health-related products and services.

Industry Overview in Poland

The Polish biotechnology landscape is witnessing significant advancements, marked by increased investment in research and development. With the growing awareness of genomic medicine and personalized health strategies, there has been a surge in demand for i